Cardiol Therapeutics Inc. Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity
Cardiol Therapeutics Inc. (CRDL) reported Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity of -CAD 31.64 million for the 12-month period ending 2021-12-31, per its 40-F/A filed 2022-04-20.
Discontinued › Notes
ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity · last filed 2022-04-20
| Period end | Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity 12 month |
|---|---|
| 2021-12-31 | -31.64M CAD 40-F/A · filed 2022-04-20 |
| 2020-12-31 | -20.64M CAD 40-F/A · filed 2022-04-20 |